ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 134 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $190,447,555 | -36.2% | 9,493,896 | -10.2% | 0.02% | -36.0% |
| Q2 2023 | $298,365,097 | -2.7% | 10,576,572 | -40.7% | 0.02% | +78.6% |
| Q1 2023 | $306,598,634 | +92.5% | 17,825,502 | +125.4% | 0.01% | -12.5% |
| Q4 2022 | $159,290,805 | -2.8% | 7,909,176 | +4.5% | 0.02% | -5.9% |
| Q3 2022 | $163,958,000 | -25.0% | 7,569,606 | -2.7% | 0.02% | -22.7% |
| Q2 2022 | $218,510,000 | -29.8% | 7,776,168 | +15.3% | 0.02% | -12.0% |
| Q1 2022 | $311,109,000 | -45.5% | 6,742,694 | -0.8% | 0.02% | -40.5% |
| Q4 2021 | $571,257,000 | +26.8% | 6,795,831 | +0.6% | 0.04% | +16.7% |
| Q3 2021 | $450,348,000 | +27.1% | 6,757,935 | +1.4% | 0.04% | +28.6% |
| Q2 2021 | $354,431,000 | +32.7% | 6,662,225 | +8.2% | 0.03% | +21.7% |
| Q1 2021 | $267,111,000 | -15.6% | 6,156,042 | +1.0% | 0.02% | -17.9% |
| Q4 2020 | $316,422,000 | +238.7% | 6,092,078 | +113.2% | 0.03% | +211.1% |
| Q3 2020 | $93,425,000 | -15.8% | 2,857,920 | +23.7% | 0.01% | -25.0% |
| Q2 2020 | $110,972,000 | – | 2,310,946 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,426,095 | $111,940,000 | 6.63% |
| Paradigm Biocapital Advisors LP | 287,577 | $13,269,000 | 3.51% |
| Avidity Partners Management LP | 3,176,999 | $146,587,000 | 3.05% |
| Integral Health Asset Management, LLC | 215,000 | $9,920,000 | 2.58% |
| Matrix Capital Management Company, LP | 4,349,279 | $200,676,000 | 2.41% |
| Affinity Asset Advisors, LLC | 207,500 | $9,574,000 | 1.53% |
| Ikarian Capital, LLC | 202,203 | $9,329,000 | 1.23% |
| Ghost Tree Capital, LLC | 80,000 | $3,691,000 | 0.80% |
| Eventide Asset Management | 761,000 | $35,113,000 | 0.55% |
| Perceptive Advisors | 501,509 | $23,140,000 | 0.46% |